ASND - Ascendis Pharma A/S - ADR
IEX Last Trade
138.605
0.665 0.480%
Share volume: 222,669
Last Updated: Fri 30 Aug 2024 09:59:34 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$137.94
0.67
0.48%
Fundamental analysis
9%
Profitability
0%
Dept financing
3%
Liquidity
50%
Performance
10%
Performance
5 Days
-0.88%
1 Month
3.37%
3 Months
0.73%
6 Months
-5.77%
1 Year
43.38%
2 Year
60.80%
Key data
Stock price
$138.60
DAY RANGE
N/A - N/A
52 WEEK RANGE
$85.29 - $161.00
52 WEEK CHANGE
$0.41
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Jan Moeller Mikkelsen
Region: US
Website: http://www.ascendispharma.com/
Employees: 872
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.ascendispharma.com/
Employees: 872
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Recent news